10.1248/cpb.46.697
The research focuses on the synthesis of HIV-protease inhibitors that incorporate a peptide moiety capable of binding to gp120, a protein on the surface of the HIV virus. The study was motivated by the need to develop therapeutic agents to inhibit the replication of HIV, the virus responsible for AIDS. Z-AHPA and phenoxyacetyl chloride are essential components in the synthesis of HIV-protease inhibitors with a peptide moiety designed to bind to gp120. Z-AHPA is prepared from L-Phe according to a reported procedure. Phenoxyacetyl chloride is synthesized by reacting phenoxyacetic acid with thionyl chloride (SOCl2) or another suitable chlorinating agent. Z-AHPA provides the core peptide structure, while phenoxyacetyl chloride enables the introduction of functional groups that enhance the binding properties of the final compounds. The successful incorporation of these components leads to the development of inhibitors with significant anti-HIV activity and protease-inhibitory properties.